You searched for metabolic diseases - Page 48 of 62

News and Trends 10 Sep 2021

The Top European Biotech Funding Rounds in August

…metabolic diseases involving the liver. And NRG Therapeutics in the UK closed a small seed investment of around £490,000 (€570,000) in a bid to treat Parkinson’s disease. One interesting seed…

September 10, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 4 Oct 2022

TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies

…aspects of clinical drug development. It acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them. TrialSpark’s current therapeutic areas of focus include rheumatology, dermatology, CNS, and cardiometabolic diseases….

October 4, 2022 - 2 minutesmins - By Jim Cornall

In Depth 5 Dec 2024

The biggest private biotech investments in November 2024

…million in series B funding. The company is focused on advancing the next generation of therapies for obesity and metabolic diseases, and the proceeds from this financing round will go…

December 5, 2024 - 3 minutesmins - By Willow Shah-Neville

News and Trends 11 Jul 2022

Treatment for cancer-associated thrombosis fast-tracked by FDA

A clinical-stage biotechnology company that develops therapies for cardiovascular and metabolic diseases today (July 11) announced it has been granted fast track designation by the US Food and Drug Administration…

July 11, 2022 - 4 minutesmins - By Liza Laws

News and Trends 2 Dec 2016

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

…peptides, hence the company’s name, has lured AstraZeneca into offering over €1B for the development of drug candidates for respiratory, cardiovascular and metabolic diseases. Bicycles, the bicyclic peptides developed at…

December 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Nov 2016

This has been the Worst Financial Year for Biotech in a Decade

A presentation on the financial state of biotech kicked off BIO-Europe in Cologne this week. The hostile American political climate has done some damage. There’s a political storm brewing across…

November 10, 2016 - 4 minutesmins - By Evelyn Warner

News and Trends 1 Nov 2022

J.P. Morgan launches life sciences private capital team

…diseases, autoimmunity, AI/ML platforms, metabolic diseases and neuropsychology. The new team sits within J.P. Morgan Private Capital, a growth equity and private credit investment platform. The platform finances private companies…

November 1, 2022 - 2 minutesmins - By Jim Cornall

More News! 10 Dec 2024

Biotech in 2024: A retrospective

…a potential paradigm shift in treatment, especially given its convenient oral administration. Jeremy Levin, CEO of Ovid Therapeutics, compares the rising success of GLP-1 therapies in cardiometabolic diseases to the…

December 10, 2024 - 14 minutesmins - By Jules Adam

News and Trends 22 Nov 2022

Arecor to start second type 2 diabetes clinical trial

…trial will be conducted at the Medical University of Graz, Austria, a research facility in metabolic diseases research and euglycemic clamp methodology, with Thomas Pieber as the trial’s principal investigator….

November 22, 2022 - 3 minutesmins - By Jim Cornall

Interview 26 Feb 2018

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

…of drug discovery [and] different departments ranging from urology to metabolic diseases, and then later on working in the pain area,” Westbrook told me. During his time there, he came…

February 26, 2018 - 9 minutesmins - By Alex Dale

News and Trends 25 Nov 2024

Evotec on the brink of acquisition: At what cost for the biotech industry?

…pipeline spans over 200 co-owned assets, covering various therapeutic areas such as oncology, neurology, and metabolic diseases. Evotec also invests in early-stage biotech startups and academic spinouts, bridging the gap…

November 25, 2024 - 8 minutesmins - By Jules Adam

Startup Scout 30 Jun 2017

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

Apart from boasting big players in the space of metabolic diseases including Novo Nordisk and Zealand Pharma, Copenhagen is a hotspot for research on obesity and diabetes. This week we…

June 30, 2017 - 2 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

The Top European Biotech Funding Rounds in August

TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies

The biggest private biotech investments in November 2024

Treatment for cancer-associated thrombosis fast-tracked by FDA

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

This has been the Worst Financial Year for Biotech in a Decade

J.P. Morgan launches life sciences private capital team

Biotech in 2024: A retrospective

Arecor to start second type 2 diabetes clinical trial

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

Evotec on the brink of acquisition: At what cost for the biotech industry?

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!